RMC No. 17-2022: Publishes the full text of letter from the DOH endorsing updates to the List of VAT-Exempt COVID-19 Medicines under RA No. 11534

Files
Download this file

Summary

RMC No. 17-2022 publishes the full text of a Department of Health letter endorsing updates to the List of VAT-Exempt Drugs and Vaccines Prescribed and Directly Used for COVID-19 Treatment under RA No. 11534 (CREATE Act).

Key points

  1. Letter published. The letter comes from Undersecretary Charade B. Mercado-Grande of the Department of Health.
  2. Updated list. The list now includes Molnupiravir 200 mg capsule, brand name Molnarz.

Summary by Tax Resources PH. It is not a substitute for the full text of the issuance or professional advice.

Copies of BIR issuances are hosted here for reference. For the official version, check bir.gov.ph. Summaries by Tax Resources PH are not a substitute for the full text or professional advice.